Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity.

Thomas P ReithMelissa A PrahEun-Jung ChoiJongho LeeRobert WujekMona Al-GizawiyChristopher R ChitambarJennifer M ConnellyKathleen M Schmainda

Published in: Tomography (Ann Arbor, Mich.) (2022)

The basal ganglia iron content increased with glioma severity. Basal ganglia iron levels may thus be a useful biomarker in glioma prognosis and treatment, especially with regard to iron-based cancer therapies.

Keyphrases

iron deficiency
high resolution
papillary thyroid
squamous cell carcinoma
mass spectrometry
high density
lymph node metastasis